TerminatedNot applicableNCT00946283
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rutgers, The State University of New Jersey
- Principal Investigator
- Roger Strair, MD, PhD, FNP-BCRutgers Cancer Institute of New Jersey
- Intervention
- Lactobacillus rhamnosus GG(dietary_supplement)
- Enrollment
- 30 enrolled
- Eligibility
- 18-120 years · All sexes
- Timeline
- 2010 – 2015
Study locations (1)
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Collaborators
National Cancer Institute (NCI) · Rutgers Cancer Institute of New Jersey
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00946283 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.